Автор |
Clagett, G., Patrick |
Дата выпуска |
1990 |
Издатель |
Sage Publications |
Название |
Antithrombotic Drugs and Vascular Surgery |
Тип |
Other |
DOI |
10.1177/153100359000300213 |
Print ISSN |
1531-0035 |
Журнал |
Perspectives in Vascular Surgery and Endovascular Therapy |
Том |
3 |
Первая страница |
79 |
Последняя страница |
102 |
Выпуск |
2 |
Библиографическая ссылка |
Harker LA, Gent M.The use of agents that modify platelet function in the management of thrombotic disorders. In Colman RW, Hirsh J, Marder VJ , Salzman EW, eds. Hemostasis and Thrombosis, 2nd ed. Philadelphia : JB Lippincott, 1987 , pp 1438-1456. |
Библиографическая ссылка |
Antiplatelet Trialists' Collaboration.Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J296:320-333, 1988. |
Библиографическая ссылка |
O'Reilly RATherapeutic modalities for thrombotic disorders. In Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis , 2nd ed. Philadelphia: JB Lippincott, 1987 , pp 1367-1372. |
Библиографическая ссылка |
Rosenberg RDBiochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med87(3B):2S-9S, 1989. |
Библиографическая ссылка |
Rowland M., Riegelman S., Harris PA, et al. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci61:379, 1972. |
Библиографическая ссылка |
Ali M., McDonald JWD, Thiessen JJ, Coates PEPlasma acetylsalicylate and salicylate and enteric-coated aspirin . Stroke 11:9-13, 1980. |
Библиографическая ссылка |
Levy G.Clinical pharmacokinetics of aspirin. Pediatrics62:867, 1978. |
Библиографическая ссылка |
Jakubowski JA , Stampfer MJ, Vaillancourt R., et al. Cumulative anti-platelet effect of low-dose enteric-coated aspirin. Br J Haematol 60:635-642, 1985. |
Библиографическая ссылка |
Cohen A.Fecal blood loss and plasma salicylate study of salicylic acid and aspirin . J Clin Pharmacol 19:242-247, 1979. |
Библиографическая ссылка |
Fromm D.Salicylate and gastric mucosal damage. Pediatrics62:938, 1978. |
Библиографическая ссылка |
UK-TIA Study Group.United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results. Br Med J296:316-320, 1988. |
Библиографическая ссылка |
Roth GJ, Majerus PW The mechanism of the effect of aspirin on human platelet . I. Acetylation of a particulate fraction protein. J Clin Invest 56:624, 1975. |
Библиографическая ссылка |
Roth GJ, Stanford N., Majerus PW Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA73:3073, 1975. |
Библиографическая ссылка |
Burch JW, Stanford N., Majerus PW Inhibition of platelet prostaglandin synthetase by oral aspirin . J Clin Invest 61:314, 1978. |
Библиографическая ссылка |
Gorman RR, Fitzpatrick FA, Miller OVA selective thromboxane synthetase inhibitor blocks the cyclic AMP lowering activity of PGH2. Biochem Biophys Res Commun79:305, 1977. |
Библиографическая ссылка |
Weiss HJ, Aledort LM, Kochwa S.The effect of salicylates on the hemostatic properties of platelet in man . J Clin Invest 47:2169, 1968. |
Библиографическая ссылка |
Wong LT, Zawidzka Z., Thomas RBEffect of acetylsalicylic acid, sulphinpyrazone and their combination of collagen-induced platelet aggregation in guinea pigs. Pharmacol Res Commun10:939, 1979. |
Библиографическая ссылка |
Packham MAStages in the interaction of platelets with collagen. Thromb Haemost36: 269, 1976. |
Библиографическая ссылка |
Packham MA, Kinlough-Rathbone RL, Reimers HJ, et al. Mechanisms of platelet aggregation independent of adenosine diphosphate. In Silver MJ, Smith JB, Kocsis JJ, eds. Prostaglandins in Hematology. New York: Spectrum Publishing, 1977 , p 247. |
Библиографическая ссылка |
TschoppThB. Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: An assessment of platelet adhesion and deposited platelet mass by morphometry and 51Cr-labelling. Thromb Res11:619, 1977. |
Библиографическая ссылка |
Patrignani P., Fiblabozzi P., Patrono C.Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest69:1366, 1982. |
Библиографическая ссылка |
Karwande SV , Weksler BB, Gay WA, et al. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. Ann Thorac Surg 43:318-322, 1987. |
Библиографическая ссылка |
Hirsh J.Progress review: The relationship between dose of aspirin, side-effects and antithrombotic effectiveness. Stroke16:1-4, 1985. |
Библиографическая ссылка |
Mills DCB.Platelet aggregation and the adenylate cyclase system. In Mills DCB, Pareti FI, eds. Platelets and Thrombosis. London : Academic Press, 1977, p 63. |
Библиографическая ссылка |
Bunag RD, Doublas R., Imai RMInfluence of a pyrimidopyrimidine derivative on deamination of adenosine by blood. Circ Res15:83, 1964. |
Библиографическая ссылка |
Ally AI, Manku MS, Horrobin DG, et al. Dipyridamole: A possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle. Prostaglandins14:607, 1977. |
Библиографическая ссылка |
Emmons PR, Harrison MJG, Honour AJ, et al. Effect of dipyridamole on human platelet behaviour. Lancet2:603, 1965. |
Библиографическая ссылка |
Zucker MB, Peterson J.Effect of acetylsalicylic acid, other nonsteroidal antiinflammatory agents and dipyridamole on human blood platelets. J Lab Clin Med76:66, 1970. |
Библиографическая ссылка |
Harker LAPlatelet survival time: Its measurement and use. In Spaet TH, ed. Progress in Hemostasis and Thrombosis, vol 4. New York : Grune & Stratton, 1978, pp 321-347. |
Библиографическая ссылка |
FitzGerald GADipyridamole. N Engl J Med316:1247-1257, 1987. |
Библиографическая ссылка |
Aberg M., Hedner U., Bergentz SEThe antithrombotic effect of dextran. Scand J Haematol34:61, 1979. |
Библиографическая ссылка |
Weiss HJThe effect of clinical dextran on platelet aggregation, adhesion and ADP release in man: In vivo and in vitro studies. J Lab Clin Med69:37, 1967. |
Библиографическая ссылка |
Aberg M., Hedner U., Bergentz SEEffect of dextran on factor VIII (antihemophilic factor) and platelet function . Ann Surg 189:182-243, 1979. |
Библиографическая ссылка |
Muzaffar TZ , Stalker AL, Bryce WAJ, et al. Dextrans and fibrin morphology. Nature 238: 288-290, 1972. |
Библиографическая ссылка |
Dhall TZ, Bryce WAJ, Dhall DPEffects of dextran on the molecular structure and tensile behaviour of human fibrin. Thromb Haemost35:737-745, 1976. |
Библиографическая ссылка |
Aberg M., Bergentz SE, Hedner U.The effect of dextran on the lysability of ex vivo thrombi. Ann Surg181:342-345, 1975. |
Библиографическая ссылка |
Shoenfeld NA , Elldrup-Jorgensen J., Connolly R., et al. The effect of low molecular weight dextran on platelet deposition onto prosthetic materials . J Vasc Surg 5:76-82, 1987. |
Библиографическая ссылка |
Ring J., Messmer K.Incidence and severity of anaphylactoid reactions to colloid volume substitutes . Lancet 1:466, 1977. |
Библиографическая ссылка |
Defreyn G., Bernat A., Delebassee D., Maffrand J-P.Pharmacology of ticlopidine: A review. Semin Thromb Hemost15(2):159-166, 1989. |
Библиографическая ссылка |
Feliste R., Delebassee D., Simon MF, et al. Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res48:403-415, 1987. |
Библиографическая ссылка |
Gachet C., Stierle A., Bouloux C., et al. The thienopyridine PCR 4099 inhibits the ADP aggregation pathway of human platelets by interfering with the binding of fibrinogen to the glycoprotein IIb-IIIa complex [abstr]. Thromb Haemost58:211, 1987. |
Библиографическая ссылка |
Ellis DJ, Roe RL, Bruno JJ, et al. The effects of ticlopidine hydrochloride on bleeding time and platelet function in man [abstr]. Thromb Haemost46:1973, 1981. |
Библиографическая ссылка |
Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med321:501-507, 1989. |
Библиографическая ссылка |
Gent M., Easton JD, Hachinski VC, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet1:1215-1220, 1989 . |
Библиографическая ссылка |
Panak E., Maffrand J-P., Picard-Fraire C., et al. A promise for the prevention and treatment of thrombosis and its complications. Haemostasis13(Suppl 1):1-52, 1983. |
Библиографическая ссылка |
Palareti G. , Poggi M., Torricelli P., et al. Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease . Thromb Res 52:621-629, 1988. |
Библиографическая ссылка |
Arcan JC, Panak E.Ticlopidine in the treatment of peripheral occlusive arterial disease . Semin Thromb Hemost 15:167-170, 1989. |
Библиографическая ссылка |
Balsano F., Coccheri S., Libretti A., et al. Ticlopidine in the treatment of intermittent claudication: A 21-month double-blind trial. J Lab Clin Med114:84-91, 1989. |
Библиографическая ссылка |
Szilagyi DE, Elliott JP, Hageman JH, et al. Biologic fate of autogenous vein implants as arterial substitutes: Clinical, angiographic and histopathologic observations in femoropopliteal operations for atherosclerosis. Ann Surg178:232-246, 1973. |
Библиографическая ссылка |
Hagen PO, Wang ZG, Mikat EM, et al. Antiplatelet therapy reduces aortic intimal hyperplasia distal to small-diameter vascular prostheses (PTFE) in nonhuman primates. Ann Surg195:328-339, 1982. |
Библиографическая ссылка |
McCann RL, Hagen PO, Fuchs JCA.Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts. Ann Surg191:238-243, 1980. |
Библиографическая ссылка |
Metke MP, Lie JT, Fuster V., et al. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol43:1144-1148, 1979. |
Библиографическая ссылка |
Clowes AW, Karnovsky MJFailure of certain antiplatelet drugs to affect myointimal thickening following arterial injury. Lab Invest36:452-458, 1977. |
Библиографическая ссылка |
Bomberger RA , DePalma RG, Ambrose TA, et al. Aspirin and dipyridamole inhibit endothelial healing. Arch Surg 117:1459-1464, 1982 . |
Библиографическая ссылка |
Unni KK, Kottke BA, Titus JL, et al. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol34:526-532, 1974. |
Библиографическая ссылка |
Fuster V., Chesebro JHRole of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation73:227-232, 1986. |
Библиографическая ссылка |
Goldman MD, Simpson D., Hawker RJ, et al. Aspirin and dipyridamole reduced platelet deposition on prosthetic femoro-popliteal grafts in man. Ann Surg198:713-716, 1983. |
Библиографическая ссылка |
Pumphrey CW , Chesebro JH, Dewanjee MK, et al. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111—labeled platelets: Effect of dipyridamole and aspirin. Am J Cardiol 51:796-801, 1983. |
Библиографическая ссылка |
Stratton JR , Ritchie JL Failure of ticlopidine to inhibit deposition of indium-111I-labeled platelets on Dacron prosthetic surfaces in humans. Circulation 69:677-683, 1984. |
Библиографическая ссылка |
Stratton JR , Ritchie JL The effects of sulfinpyrazone on platelet deposition on Dacron vascular grafts in man. Am Heart J 109:453-457, 1985. |
Библиографическая ссылка |
Stratton JR , Ritchie JL Reduction of indium-111 platelet deposition on Dacron vascular grafts in humans by aspirin plus dipyridamole . Circulation 73:325-330, 1986. |
Библиографическая ссылка |
Goldman M., Norcott HC, Hawker RJ, et al. Platelet accumulation on mature Dacron grafts in man. Br J Surg69:S38-S40, 1982. |
Библиографическая ссылка |
Mayer JE, Lindsay WG, Castaneda W., et al. Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts. Ann Thorac Surg31:204-210, 1981. |
Библиографическая ссылка |
Chesebro JH , Clements IP, Fuster V., et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 307:73-78, 1982. |
Библиографическая ссылка |
Chesebro JH , Fuster V., Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 310:209-214, 1984. |
Библиографическая ссылка |
Lorenz RL, Schacky CV, Weber M., et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): Effects on platelet aggregation and thromboxane formation. Lancet1:1261-1264, 1984. |
Библиографическая ссылка |
Brown BG, Cukingnan RA, DeRouen T., et al. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation72:138-146, 1985. |
Библиографическая ссылка |
Rajah SM, Salter MCP, Donaldson DR, et al. Acetvlsalicvlic acid and dipyridamole improve the early patency of aorto-coronary bypass grafts: A double-blind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg90:373-377, 1985. |
Библиографическая ссылка |
Goldman S., Copeland J., Moritz T., et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration Cooperative StudyCirculation77:1324-1332, 1988. |
Библиографическая ссылка |
Pfisterer M. , Jockers G., Regenass S., et al. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion . Lancet 2:1-6, 1989. |
Библиографическая ссылка |
Pantely GA, Goodnight SH, Rahimtoola SH, et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: A controlled, randomized study . N Engl J Med 301:962-966, 1979. |
Библиографическая ссылка |
McEnany MT, Salzman EW, Mundth ED, et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery. J Thorac Cardiovasc Surg83:81-89, 1982. |
Библиографическая ссылка |
Sharma Gvrk , Khuri SF, Josa M., et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency . Circulation 68 (Suppl II):218-221, 1983. |
Библиографическая ссылка |
Brooks N., Wright J., Sturridge M., et al. Randomised placebo-controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. Br Heart J53:201-207, 1985. |
Библиографическая ссылка |
Sethi GK, Copeland JG, Goldman S., et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol15: 15-20, 1990. |
Библиографическая ссылка |
Green RM, Roedersheimer R., DeWeese JAEffects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery92:1016-1026, 1982 . |
Библиографическая ссылка |
Goldman M., Hall C., Dykes J., et al. Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br J Surg70:635-638, 1983. |
Библиографическая ссылка |
Kohler TR, Kaufman JL, Kacoyanis G., et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery96:462-466, 1984. |
Библиографическая ссылка |
Clyne CAC , Archer TJ, Atuhaire LK, et al. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts. Br J Surg 74:246-248, 1987. |
Библиографическая ссылка |
McCollum C. , Alexander C., Kenchington G., et al. Antiplatelet drugs in femoro-popliteal vein bypass: A multicentre trial. J Vasc Surg (in press). |
Библиографическая ссылка |
Hennekens CH , Buring JE, Sandercock P., et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 80:749-756, 1989. |
Библиографическая ссылка |
Kretschmer G., Pratschner T., Prager M., et al. Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy: Analysis of the clinical series followed by a controlled trial. Ann Surg211:317-322, 1990. |
Библиографическая ссылка |
Rutherford RB, Jones DN, Bergentz SE, et al. The efficacy of dextran-40 in preventing early postoperative thrombosis following difficult lower extremity bypass . J Vasc Surg 1: 765-772, 1984. |
Библиографическая ссылка |
Kretschmer G., Wenzl E., Piza E., et al. The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: Analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. Surgery102:453-459, 1987. |
Библиографическая ссылка |
Kretschmer G., Schemper M., Ehringer H., et al. Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery. Lancet1:797, 1988. |
Библиографическая ссылка |
Arfvidsson B., Lundgren F., Drott C., et al. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery . Am J Surg 159:556-560, 1990. |
Библиографическая ссылка |
Hirsh J., Poller L., Deykin D., et al. Optimal therapeutic range for oral anticoagulants. Chest95:5S-11S, 1989. |
Библиографическая ссылка |
Hull R., Hirsh J., Jay R., et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med307:1676-1681, 1982. |
Библиографическая ссылка |
Turpie ACG , Gunstensen J., Hirsh J., et al. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1:1241, 1988. |
Библиографическая ссылка |
Saour JN, Sieck JO, Mamo LAR, Gallus ASTrial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med322:428, 1990. |
Библиографическая ссылка |
Baxter BT, Bergman RT, McCarthy WJ, et al. Prospective assessment of antithrombotic therapy following primary below-knee prosthetic bypass. J Vasc Surg (in press). |
Библиографическая ссылка |
Salzman EW, Hirsh J.Prevention of venous thromboembolism. In Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis, 2nd ed. Philadelphia: JB Lippincott, 1987 , pp 1252-1265. |
Библиографическая ссылка |
Clagett GP, Genton E., Salzman EW, Antithrombotic therapy in peripheral vascular disease. Chest95:128S-139S, 1989. |
Библиографическая ссылка |
Collins GJ Jr, Kimball DB, Rich NM, et al. Heparin utilization during arterial revascularization. Am Surg44:753-757, 1978. |
Библиографическая ссылка |
Effeney DJ, Goldstone J., Chin D., et al. Intraoperative anticoagulation in cardiovascular surgery. Surgery90:1068-1074, 1981. |
Библиографическая ссылка |
Weksler BB, Lewin M.Anticoagulation in cerebral ischemia. Stroke14:658-663, 1983. |
Библиографическая ссылка |
Bousser MG, Eschwege E., Haguenau M., et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke14:5, 1983. |
Библиографическая ссылка |
CanadianCooperative Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med299:53, 1978. |
Библиографическая ссылка |
Fields WS, Lemak N., Frankowski RF, et al. Controlled trial of aspirin in cerebral ischemia. Stroke8:301-314, 1977. |
Библиографическая ссылка |
Sorensen PS , Pedersen H., Marquardsen J., et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attack. A Danish Cooperative Study. Stroke 14:15, 1983. |
Библиографическая ссылка |
A. SwedishCooperative Study. High-dose acetylsalicylic acid after cerebral infarction. Stroke18:325-334, 1987. |
Библиографическая ссылка |
Ramirez-Lassepas M., Cipolle RJMedical treatment of transient ischemic attacks: Does it influence mortality?Stroke19:397-400, 1988. |
Библиографическая ссылка |
Whisnant JP , Sandok BA, Sundt TM Carotid endarterectomy for unilateral carotid system transient cerebral ischemia. Mayo Clin Proc 58:171-175, 1983. |
Библиографическая ссылка |
NorthAmerican Symptomatic Carotid Endarterectomy Study Group. Carotid endarterectomy: Three critical evaluations. Stroke18:987-989, 1987. |
Библиографическая ссылка |
Stratton JR , Zierler E., Kazmers A. Platelet deposition at carotid endarterectomy sites in humans. Stroke 18:722-727, 1987. |
Библиографическая ссылка |
Findlay JM , Lougheed WM, Gentili F., et al. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation . J Neurosurg 63:693-698, 1985. |
Библиографическая ссылка |
Fields WS, Lemak NA, Frankowski RF, Hardy RJControlled trial of aspirin in cerebral ischemia. II. Surgical group. Stroke9:309, 1978. |
Библиографическая ссылка |
Clagett GP , Rich NM, McDonald PT, et al. Etiologic factors for recurrent carotid artery stenosis. Surgery 93:313, 1983. |
Библиографическая ссылка |
Cossman D. , Callow AD, Stein A., et al. Early restenosis after carotid endarterectomy . Arch Surg 113:275, 1978. |
Библиографическая ссылка |
Reunanen A. , Takkunen H., Aromass A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 211:249-256, 1982. |
Библиографическая ссылка |
Criqui MH, Fronek A., Barrett-Connor E., et al. The prevalence of peripheral arterial disease in a defined population . Circulation 71:510-515, 1985. |
Библиографическая ссылка |
Jelnes R., Gaardsting O., Jensen KH, et al. Fate in intermittent claudication: Outcome and risk factors . Br Med J 293:1137-1140, 1986 . |
Библиографическая ссылка |
Steering Committee of the Physicians' Health Study Research Group.Preliminary report: Findings from the aspirin component of the ongoing physicians' health study. N Engl J Med318:262-264, 1988. |
Библиографическая ссылка |
Peto R., Gray R., Collins R., et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J296:313-316, 1988. |
Библиографическая ссылка |
Relman ASAspirin for the primary prevention of myocardial infarction [editorial] . N Engl J Med 318:245-246, 1988. |
Библиографическая ссылка |
Boissel JP , Peyrieux JC, Destors JM Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs? Thromb Haemost 62:681-685, 1989. |
Библиографическая ссылка |
Wilentz JR , Sanborn TA, Haudenschild CC, et al. Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury. Circulation 75:636, 1987. |
Библиографическая ссылка |
Cunningham DA, Kumar B., Siegel BA, et al. Aspirin inhibition of platelet deposition at angioplasty sites: Demonstration by platelet scintigraphy . Radiology 151:487, 1984. |
Библиографическая ссылка |
Schwartz L. , Bourassa MG, Lesperance J., et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318: 1714, 1988 . |
Библиографическая ссылка |
Minar E., Ehringer H., Ahmadi R., et al. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. Radiology170:767-772, 1989. |